Apply on Employer Site

ImmunoVec · 1 month ago

Research Associate - Lentivirus production

Los Angeles, CA

Full-time

Onsite

New Grad, Entry Level

ImmunoVec is a biotechnology company pioneering in vivo cell engineering through viral and non-viral DNA delivery. The Research Associate will adapt and execute protocols to produce high quality, high titer lentivirus, contributing to the production and screening of hundreds of viruses weekly for pre-clinical research.

BiotechnologyGeneticsHealth CareMedical

H1B Sponsor Likely

Responsibilities

Crypreserve, thaw, and culture cell lines (primarily HEK293T and HT29) using aseptic technique

Transduce cultures of HEK293T cells with lentiviral plasmids to produce virus-like particles

Determine the titer of each viral prep using transduction assays and confirm the genetic sequence of packaged viruses using PCR followed by DNA sequencing

Collect, aliquot, and store viruses using our protocols that are optimized to produce ~120 unique viruses per week in formats that are ideal for high throughput screening

Maintain an up to date inventory of stored viruses and their genetic sequences

Concentrate large lentiviral preps via ultracentrifugation

Present the results of your work to the R&D team

Qualification

Lentivirus productionPCRDNA sequencingCell culture techniquesUltracentrifugationAttention to detailOrganizational skills

Required

A bachelor's degree in Microbiology, Immunology, Cell Biology, or a related field and substantial experience in lentivirus production

Experience in fast-paced, large scale laboratory operations, e.g. screening projects

Strong attention to detail and excellent organizational skills

Benefits

Full health, dental and vision insurance

Matching 401K

Company

ImmunoVec

ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.

Founded in 2019

Santa Monica, California, USA

2-10 employees

https://www.immunovec.com/

H1B Sponsorship

ImmunoVec has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2023 (3)

Funding

Current Stage

Early Stage

Total Funding

$45M

Key Investors

Advanced Research Projects Agency for Health

2025-09-22Grant· $40.7M

2022-03-01Seed· $4.3M

Leadership Team

Ryan Wong

Chief Executive Officer

Recent News

Pulse 2.0

ImmunoVec: $40.7 Million Raised From ARPA-H To Improve In Vivo Cell Engineering for Autoimmune Diseases

2025-10-16

FierceBiotech

US government pumps money toward in vivo cell therapy programs

2025-10-14

PR Newswire

ImmunoVec Launches from Stealth with up to $40.7 Million ARPA-H EMBODY Award to Advance In Vivo Cell Engineering Platform for Autoimmune Diseases

2025-10-09

Company data provided by crunchbase